Yatharth Hospital & Trauma Care Services Ltd Q1 FY24 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
N/A
Margin
N/A
Fundraise
N/A
Order
N/A
Capex
N/A
0 of 0 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
See what Yatharth Hospital & Trauma Care Services Ltd management said on margin guidance — free account, 30 seconds.
Fundraise plans
See what Yatharth Hospital & Trauma Care Services Ltd management said on order book — free account, 30 seconds.
Capex plans
Track Yatharth Hospital & Trauma Care Services Ltd — get its next earnings analysis in your feed
Margin guidance
Order book
How does Yatharth Hospital & Trauma Care Services Ltd rank vs peers in Healthcare Services?
Pro featureHow does Yatharth Hospital & Trauma Care Services Ltd rank in Healthcare Services?
Compare Yatharth Hospital & Trauma Care Services Ltd against every Healthcare Services company (Q1 FY24) on revenue, margins and earnings-call signals.
Continue your research
What Yatharth Hospital & Trauma Care Services Ltd's management said in earlier quarters
- Q1 FY27 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q1 FY26 earnings call analysis →
- Q4 FY25 earnings call analysis →
- Q2 FY26 earnings call →
- Q3 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
Others in Healthcare Services this season
- Metropolis Healthcare Ltd (Q1 FY27)
East India currently 6%, with limited investment so far; future investments may increase contribution. Key concall takeaways from Metropolis Healthcare Ltd's…
- Apollo Hospitals (Q1 FY27)
IP volume growth for established units guided at roughly 7% to 8%. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q1 FY27 earnings call — and how…
- Health X Platform Ltd (Q1 FY27)
July monthly revenue stood at INR 150+ crores, indicating strong growth momentum. Key concall takeaways from Health X Platform Ltd's Q1 FY27 earnings call…
- Shalby Ltd (Q1 FY27)
Shalby MedTech showed strong revenue growth: ₹47 crores in Q1 FY27, a 53% YoY increase. Key concall takeaways from Shalby Ltd's Q1 FY27 earnings call — and how…